A New Diagnostic Test for Acute Exacerbation of COPD

MOLOGIC LTD, has developed a urine-based test system ‘HeadStart’ which enables chronic obstructive pulmonary disease (COPD) patients to monitor their disease status at home for early indications of exacerbation. It will test the levels of key biomarkers in the urine, interpret them and identify imminent acute exacerbation and cause in 10 minutes.

New Diagnostic Test for Acute Exacerbation of COPD: Case Study

Links to the Innovation Pathway: Markets; Finance; Clinical Trials; Evaluation; Commercialisation; Brokering

(Uploaded on 10th August 2016)

Search the Innovation Exchange